Get the Stockscreener App
8.85
0.45%
-0.04
After Hours:
8.84
-0.010
-0.11%
Enanta Pharmaceuticals Inc Stock (ENTA) Forecast
The Enanta Pharmaceuticals Inc (ENTA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $8.0305, representing a -9.26% decrease from the current price of $8.85. The highest analyst price target is $8.6708, and the lowest is $7.3901.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENTA Price Target
Average 6.151
(-30.50% Downside)
Is Enanta Pharmaceuticals Inc (ENTA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.77 | Neutral |
| STOCH(9,6) | 60.31 | Neutral |
| STOCHRSI(14) | 36.00 | Neutral |
| MACD(12,26) | 0.3758 | Buy |
| ADX(14) | 26.31 | Buy |
| William %R | -25.40 | Neutral |
| CCI(14) | 22.12 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.732
Buy
|
8.6747
Buy
|
| MA20 |
8.243
Buy
|
8.3787
Buy
|
| MA50 |
7.7478
Buy
|
7.8182
Buy
|
| MA100 |
6.9481
Buy
|
7.4078
Buy
|
| MA200 |
6.7246
Buy
|
7.9919
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ENTA could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ENTA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60.77 indicates that ENTA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 60.31 indicates that ENTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 36 indicates that ENTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.31 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 22.12 indicates that ENTA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ENTA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Enanta Pharmaceuticals Inc financial reports and earnings history, Enanta Pharmaceuticals Inc (ENTA) stock could reach $53.57 by 2030, $37.12 by 2040 and $125.89 by 2050. See the projected annual prices until 2050 of the Enanta Pharmaceuticals Inc stock below:
- Enanta Pharmaceuticals Inc (ENTA) is expected to reach an average price of $24.95 in 2035, with a high prediction of $27.44 and a low estimate of $26.12. This indicates an $181.93% rise from the last recorded price of $8.85.
- Enanta Pharmaceuticals Inc (ENTA) stock is projected to chart a bullish course in 2040, with an average price target of $38.57, representing an $335.80% surge from its current level. The forecast ranges from a conservative $37.86 to a sky-high $37.12.
- Our analysts predict Enanta Pharmaceuticals Inc (ENTA) to jump 789.30% by 2045, soaring from $75.48 to an average price of $78.70, potentially reaching $73.11. While $75.48 is the low estimate, the potential upside is significant.
- Enanta Pharmaceuticals Inc (ENTA) stock is expected to climb by 2050, reaching an average of $123.46, a $1,295% jump from its current level. However, a wide range of estimates exists, with high and low targets of $125.89 and $128.49, respectively, highlighting the market's uncertainty.
Enanta Pharmaceuticals Inc Stock (ENTA) Year by Year Forecast
Enanta Pharmaceuticals Inc Stock (ENTA) Price Forecast for 2025
Enanta Pharmaceuticals Inc Stock (ENTA) is expected to reach an average price of $9.0234 in 2025, with a high prediction of $14.08 and a low estimate of $3.9693. This indicates an +1.96% rise from the last recorded price of $8.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $9.1366 | $7.3901 | $8.6708 | +3.24% |
| November, 2025 | $11.17 | $11.72 | $11.73 | +26.24% |
| December, 2025 | $12.25 | $12.24 | $11.12 | +38.47% |
Enanta Pharmaceuticals Inc Stock (ENTA) Price Forecast for 2026
The predicted value for Enanta Pharmaceuticals Inc (ENTA) in 2026 is set at an average of $7.1189. Estimates vary from a peak of $14.02 to a trough of $0.2148, indicating an -19.56% surge from the present price of $8.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.13 | $10.59 | $9.8888 | +37.07% |
| February, 2026 | $10.11 | $12.10 | $11.82 | +14.19% |
| March, 2026 | $6.602 | $8.132 | $10.46 | -25.40% |
| April, 2026 | $0.1158 | $1.4578 | $4.5022 | -98.69% |
| May, 2026 | $0.62 | $1.02 | $1.55 | -92.99% |
| June, 2026 | $1.7958 | $1.9594 | $2.0335 | -79.71% |
| July, 2026 | $2.0919 | $0.4852 | $4.0684 | -76.36% |
| August, 2026 | $1.4839 | $1.171 | $2.3355 | -83.23% |
| September, 2026 | $4.0861 | $2.9103 | $3.2861 | -53.83% |
| October, 2026 | $1.7909 | $5.4219 | $4.149 | -79.76% |
| November, 2026 | $11.35 | $0.2148 | $11.40 | +28.27% |
| December, 2026 | $11.85 | $8.5965 | $14.02 | +33.90% |
Enanta Pharmaceuticals Inc Stock (ENTA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Enanta Pharmaceuticals Inc (ENTA) is $29.82, with a high forecast of $58.50 and a low forecast of $1.1385. This indicates an +236.95% increase from the last price of $8.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $30.03 | $12.69 | $30.07 | +239.37% |
| February, 2027 | $32.26 | $29.61 | $58.50 | +264.50% |
| March, 2027 | $32.94 | $24.30 | $50.04 | +272.16% |
| April, 2027 | $18.85 | $17.16 | $38.61 | +113.00% |
| May, 2027 | $21.04 | $13.70 | $22.23 | +137.79% |
| June, 2027 | $27.81 | $19.56 | $31.88 | +214.26% |
| July, 2027 | $32.81 | $24.70 | $34.55 | +270.70% |
| August, 2027 | $31.47 | $31.12 | $41.55 | +255.60% |
| September, 2027 | $3.0185 | $1.1385 | $33.29 | -65.89% |
| October, 2027 | $5.1527 | $2.1621 | $9.1592 | -41.78% |
| November, 2027 | $18.02 | $4.7763 | $20.46 | +103.58% |
| December, 2027 | $34.31 | $13.32 | $42.68 | +287.74% |
Enanta Pharmaceuticals Inc Stock (ENTA) Price Forecast for 2028
In 2028, Enanta Pharmaceuticals Inc (ENTA) is projected to reach an average price of $19.48, with a high projection of $38.83 and a low estimate of $0.1351. This indicates an +120.13% rise from the last price of $8.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $31.05 | $24.83 | $38.83 | +250.83% |
| February, 2028 | $19.90 | $17.43 | $32.00 | +124.89% |
| March, 2028 | $14.21 | $12.53 | $22.45 | +60.57% |
| April, 2028 | $11.54 | $9.5244 | $19.44 | +30.34% |
| May, 2028 | $18.08 | $9.7686 | $18.95 | +104.33% |
| June, 2028 | $22.16 | $15.22 | $25.75 | +150.36% |
| July, 2028 | $25.77 | $21.05 | $34.79 | +191.20% |
| August, 2028 | $18.89 | $17.68 | $27.88 | +113.43% |
| September, 2028 | $14.50 | $12.60 | $21.33 | +63.88% |
| October, 2028 | $11.53 | $8.4738 | $14.64 | +30.25% |
| November, 2028 | $2.5051 | $0.1351 | $11.76 | -71.69% |
| December, 2028 | $1.1707 | $0.1872 | $3.6987 | -86.77% |
Enanta Pharmaceuticals Inc Stock (ENTA) Price Forecast for 2029
The 2029 price forecast for Enanta Pharmaceuticals Inc Stock (ENTA) is $27.46 on average, with a high prediction of $54.83 and a low estimate of $0.0967. This represents an +210.32% increase from the previous price of $8.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.5329 | $2.8671 | $2.5865 | -71.38% |
| February, 2029 | $4.9787 | $3.1694 | $4.7773 | -43.74% |
| March, 2029 | $7.0645 | $5.5851 | $5.788 | -20.18% |
| April, 2029 | $9.3103 | $7.9209 | $8.6503 | +5.20% |
| May, 2029 | $9.6125 | $9.3861 | $9.2132 | +8.62% |
| June, 2029 | $7.2583 | $7.9083 | $8.434 | -17.98% |
| July, 2029 | $6.7541 | $7.0841 | $6.8977 | -23.68% |
| August, 2029 | $2.9464 | $3.1344 | $3.7306 | -66.71% |
| September, 2029 | $0.7822 | $1.9922 | $1.92 | -91.16% |
| October, 2029 | $1.4156 | $0.2956 | $2.6485 | -84.00% |
| November, 2029 | $0.9998 | $0.4498 | $5.0527 | -88.70% |
| December, 2029 | $60.69 | $0.0967 | $54.83 | +585.76% |
Enanta Pharmaceuticals Inc Stock (ENTA) Price Forecast for 2030
Enanta Pharmaceuticals Inc Stock (ENTA) is expected to reach an average price of $67.71 in 2030, with a high forecast of $78.49 and a low forecast of $56.92. This signifies an +665.03% surge from the last price of $8.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $60.15 | $56.92 | $53.57 | +579.66% |
| February, 2030 | $59.42 | $60.73 | $58.64 | +571.42% |
| March, 2030 | $71.07 | $64.59 | $67.13 | +703.08% |
| April, 2030 | $70.56 | $72.00 | $68.57 | +697.28% |
| May, 2030 | $78.65 | $72.40 | $78.49 | +788.74% |
| June, 2030 | $78.02 | $78.06 | $76.85 | +781.53% |
| July, 2030 | $74.06 | $74.85 | $75.36 | +736.83% |
| August, 2030 | $69.50 | $70.96 | $70.30 | +685.27% |
| September, 2030 | $72.88 | $70.62 | $70.02 | +723.54% |
| October, 2030 | $77.62 | $74.05 | $76.03 | +777.03% |
| November, 2030 | $75.69 | $77.98 | $76.67 | +755.24% |
| December, 2030 | $76.34 | $78.93 | $77.14 | +762.61% |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):